Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Pos1091 Evaluation of the Composition and Diversity of the Gut Microbiome in a Group of Patients Diagnosed With Spondyloarthritis According to Their Exposure to Biologic Disease-Modifying Therapy (Anti-TNF or Il-17 Inhibitors): A Before and After Study

View Full Paper
Ask AI
Bookmark
Share

Authors

OCO. J. CalixtoUniversidad El BosqueDADeisy AbrilUniversidad de Los AndesARA. Ramos-CasallasUniversidad El Bosque

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Calixto et al. (2024) studied this question.

synapsesocial.com/papers/68e66db4b6db6435875f8701https://doi.org/10.1136/annrheumdis-2024-eular.1762
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1POS0810 THERAPEUTIC CHOICES-EFFICACY OF THE INTEGRATIVE MANAGEMENT AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH IBD-ASSOCIATED SPONDYLARTHRITIS: A 4-YEAR OBSERVATIONAL STUDY (THE SPIB COHORT)2024
  2. 2P0263 Enhancing early diagnosis and differential assessment of Inflammatory Bowel Disease-related spondylarthritis through a multidisciplinary strategy: findings from a cross-sectional Study2026
  3. 3Influence of biological treatments on intestinal microbiota of psoriasis patients2024 · 3 citations
  4. 4OP0085 CLINICAL FEATURES OF PATIENTS WITH SpA, WITH OR WITHOUT IBD: RESULTS FROM THE METEOR COHORT2024 · 1 citations
  5. 5POS0520 INFLAMMATORY BOWEL DISEASE IN AXIAL SPONDYLOARTHRITIS PATIENTS. IS THERE ANY SPECIFIC CLINICAL PICTURE?2024 · 1 citations